DatasetName,RPL29_S(142) RPL29_S(149) RPL29_S(150) RPL29_S(158) RPL29_S(31) RPL29_S(66),RPL29_T(151) RPL29_Y(98)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5292208844245557
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5194592891080471,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5285677747790861,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5400805767844223,
RKK2015_TNF-α/basal,0.49221327288188216,
JJ2018_Ratio H/M normalized pP2,0.5430712041602377,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5582008336922598,
HS2024_6_B_T3,0.5433990806204809,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.4253298150003019
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5249946072657293,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6050258263512297,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5464216427759742,
FSO2013_Ratio M/L normalized Rep1___1,,0.4264025559057546
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.48974958207118724,
WZ2023_Pu_010_30min,0.5282213794749723,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5441707044682967,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5799050924538666,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5537240800590756,0.42024257327344594
JJ2018_Ratio H/L normalized___1,0.5721496991891918,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.47585276350700306,
AH2018_SILAC_MR_2_N,0.5441961767936083,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5615152918660204,
AS2011_Ratio H/L Proteins Inhi_2,0.5522615566186522,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5529450051443702,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5275232366159358,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5594569732124285,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5304535796864219,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5878617042084887,
WZ2023_Pu_005_10min,0.5275989595296181,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5258136212600948,
AH2018_SILAC_MR_2_X,0.5435898095846797,
HS2024_4_PD_T2,0.5780573767150295,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5903425094657176,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,0.545404109507379,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5679598894505903,
JJ2018_Ratio M/L normalized pP3,0.5765510376429565,
AH2018_SILAC_M_2_N,0.5614795365292625,0.4384377871960926
HS2024_7_PD_T2,0.5483319266227534,
FSO2013_Ratio H/L normalized Rep1___1,,0.4360523555077387
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5828672881437135,
HS2024_3_B_N1,0.5117170184417915,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5296768637115479,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5522188256177835,0.45179465131804386
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5761871160183286,
FSO2013_Ratio H/L normalized Rep2,,0.4310880425301191
WZ2023_Pu_005_20min,0.530973253718272,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5820425715584621,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5352601829067077,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.519626280960015,
KTGR2014_Ratio-AA 7 mins,0.5441473140430008,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.559046420418996,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5734455333170113,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,0.5017672231613344,
CK2022_1 16-1,,
CK2022_1 200-1,0.5694450651636508,
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.5481479420873373,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5834226182422443,
RCJD2014_5min_1,0.5424034981624104,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5105785328882071,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5591480041254281,
KBE2022_Log2_Ex_8_T,0.6059280300715417,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,0.5313920473208067,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.5320792687291824,
AH2018_LFQ_M_2_C,0.5586885523447636,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5417165224957026,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5893832241373885,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5459857231731261,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.5475082425090635,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.562649368508339,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5654340010294943,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.554932207915853,
HS2024_8_I_T3,0.5312625041172004,
CF2017_EOC 3,0.5319145762909022,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5255601378355639,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5779720625783634,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5407217272593683,
FSO2013_Ratio H/M normalized Rep2,0.5314546088085582,0.4434920652464225
RAM2015_Log2 A,0.49129467442553304,
HS2024_8_PD_T1,0.5323015318205057,
JJ2018_Ratio H/L normalized pP2,0.5683235906505909,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5764952971937075,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5785376251453024,
AH2018_SILAC_M_3_X,0.5689773810562365,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5782586756682423,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),0.5476261753115,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.48478381934567377,
HS2024_6_B_N1,0.5355397950591024,
KBE2022_Log2_Ex_27_T,0.5872078465762484,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,0.5489742578950964,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5531961938404619,0.4185630346427465
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,0.44877595504136697
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5528823089822923,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5339652779959545,
DL2023_control-1,,
AR2021_ALG 10 μM,,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5722634043182394,0.4941787104844926
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5409802122803232,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5629124759694774,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5363085450496411,0.49941278887495716
JW2021_After_3,,
GF2025_P8_Sph,0.5012259119005885,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5669320270778,
AH2018_SILAC_2_N,0.5574113696385578,0.4345901222626898
CK2022_11 200-1,0.5705000222374632,
CK2022_12 200-1,0.5698919796700738,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5442489350110667,
WZ2023_Su_010_20min,0.5189514420792781,
AH2018_TMTMS2_2_N,0.5531985569219436,0.42335631623358977
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5857042574914082,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5891398189515646,
KS2014_Intensity N4,0.5905206157916001,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5569709523501695,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5835512220981881,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.5553481476518008,
GF2025_P1_Sph,0.5396811282655175,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.5313717002559715,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.534362191710976,
CF2017_EOC 1,0.48441254880554285,
CK2022_3 200-1,0.5678829451656399,
AH2018_LFQ_IT_3_C,0.5544146508165432,0.4557286631700959
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5547824885649595,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,0.5407518917688391,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.549820431097373,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5671011828616104,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.585867758962017,
CR2017_Ratio Replicate 3.2,0.49101616038700446,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5796752963227776,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.5015134275084818
CK2022_13 200-1,0.5569923074592671,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5266387268612346,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5792664535265507,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5520807753300647,0.451743880461957
HS2024_5_PD_T3,0.5661258576674401,
AH2018_TMTMS3_3_X,0.5764433990185028,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5931139899216956,
AH2018_LFQ_M_1_N,0.5554894451050931,
KBE2022_Log2_Ex_27_U,0.5814475704847686,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5190158785713058,
AH2018_SILAC_M_1_N,0.5429099823274531,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5975812125347165,
SR2019_SKBR3_Biol_repl_3,0.5232858335657976,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5589547253632109,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5346776310114216,0.45194405539314986
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5035804902210258,
HH2022_Reporter intensity 6,0.5368506866436541,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,0.5602874377116124,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,0.4812371056982906
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6091439283825155,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5537108160692005,0.43166628714140864
GF2025_P3_Adh,0.5581911152158846,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5571777463341631,0.41858168512874494
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.604151853392413,
KBE2022_Log2_Ex_19_U,0.5768515427410831,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5241318815869962,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.44908540992619994
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.5137621724828298
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.526562635323272,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5135237462048458,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5813106708152926,
HH2022_Reporter intensity 1,0.5640043203909956,
HH2022_Reporter intensity 2,0.5634767212308879,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.534714198090942,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5285157958141987,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5065190249628629,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5695546000741277,0.39262118208698815
AR2021_KD 72h,,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6083571734949008,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5889722968645846,
KBE2022_Log2_Ex_9_U,0.58903302084914,
AH2018_SILAC_M_3_N,0.5638965121837077,
KBE2022_Log2_Ex_13_T,0.6018370013188209,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5258367871701585,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,0.504572339872024,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5300961319206771,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5489258195594489,
SAS2015_PLX/AZD_Exp1,0.5671889146975105,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5274063484465354,0.5244636484739371
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5547126296227717,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6079242467719228,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5767990203249265,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.539848618348818,
CK2022_7 200-1,0.5508976760707183,
CK2022_5 200-1,0.5505389267870862,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.43189575465320884
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5503841788417316,
AH2018_SILAC_MR_1_X,0.5163649559109978,0.4913165407828114
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,0.5406426909651042,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5760494201925063,
AH2018_SILAC_3_C,0.5489488793149043,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5248309762868856,0.5221969630726659
CK2022_4 16-1,,
AS2011_Ratio H/L,0.5510231961557513,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,0.5587531868891138,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5523003557303919,
SAS2015_PLX/DMSO_Exp1,0.5550417950142712,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.5670774795168974,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.4599817745700614
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.551559549272716,
JJ2018_Ratio M/L normalized,0.5738494238071058,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5331634471242516,
KBE2022_Log2_Ex_9_T,0.595241111501033,
AH2018_SILAC_IT_2_N,0.5741443281850249,0.493901802212034
AH2018_SILAC_IT_1_X,0.5500668190962694,0.4368207374390073
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5525063424658091,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5065856760411114,
WZ2023_Pe_025_20min,0.5297509578310864,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.5487541622968032,
AH2018_LFQ_2_N,0.5433233805004808,
HS2024_4_I_N2,0.5485292021231287,
AH2018_TMTMS2_3_N,0.5576390582956435,0.4332638822174212
RN2012_H06,0.5559504225527374,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5680529294103677,
WZ2023_Su_005_30min,0.5323747967187037,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,0.5489742578950964,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5335258035913856,
WZ2023_Su_025_10min,0.5241005902949522,
AH2018_LFQ_IT_4_X,0.5679290483049696,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5265271596858333,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5461778395008164,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5877659370151649,0.38123391160969455
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4711143443828149,
LY2019_P7+,0.5647802124372837,
EP2017_Untreated R#1 normalized log2 ratio,0.5951897739708528,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5900465411892114,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6058346462861791,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5486019201660729,0.43313590576356764
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5521013692381231,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5683550985444767,
HS2024_8_I_T2,0.5262851995042063,
KBE2022_Log2_Ex_6_U,0.5614736861531702,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5470396624691329,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5552405945633966,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5898802860324334,
GF2025_P9_Sph,0.49943194940702035,
CK2022_6 200-1,0.5493945042808625,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5958962970511782,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5528802307948073,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5679518048125155,
SAS2015_AZD/DMSO_Exp1,0.5529883280737972,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.5778822708987685,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5513572807640089,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5869572847769785,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5361246631864282,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5666655565273374,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),0.5508676446392483,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5545621134321631,0.45571843225473174
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5487312065504947,
KBE2022_Log2_Ex_29_T,0.5827486570665896,
HS2024_7_I_T2,0.5233164152831956,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5573273017047563,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5277072091638658,0.4987107279808674
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.4913641867229602,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,0.5313357085721889,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.56270883660616,
EP2017_Untreated R#3 log2 ratio,0.5683585432240142,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,0.5569267716066869,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5825176145273923,
HS2024_8_PD_T2,0.5265225790395204,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5439167092126356,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5651885753730039,
AS2011_Ratio H/L Normalized Inhi_2,0.5592400653147511,
RKK2015_TNF-α/SC-514,0.5060476769606225,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5304858706476271,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5375008042298307,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5523550531176725,
HS2024_3_PD_T3,0.563921336804866,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5069579109889574,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5472545575153805,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5807508142606449,
CK2022_2 16-1,,
RAM2015_Log2 B,0.5134933649401994,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5604293050926394,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5642115869375355,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,0.5587531868891138,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5419562401596514,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.5193163793547827,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,0.5446432756153261,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5352106573073611,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,0.5523335800578164,
HH2022_Reporter intensity 7,0.5415391988821013,
AH2018_SILAC_M_1_X,0.5404362197883817,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.48754501339787987,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5646164324140197,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5382560475971822,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,0.5418719117840173,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5746924970129818,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5922891938856473,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5190819695668224,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5386143613154806,0.46952656069108134
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.504548542141013,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5731347480473702,
GF2025_P3_Sph,0.5335998732160522,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5400790480583343,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5490872679692542,0.4939353981703717
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,0.5727431474025385,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5400408173380887,
CR2017_Ratio Replicate 2.4,0.5880114691399655,
ZQ2022_N1,,
LY2019_P6-,0.5240569047938358,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,0.5440781994808871,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.56251579405574,
AH2018_LFQ_3_N,,0.4197588219631436
RKK2015_TNF-α/IKKb,0.5253518951831199,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5868500521963105,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5902546553483017,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,0.5491115473309623,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5719741368599308,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5485956387505672,
WZ2023_Su_025_20min,0.525698672885767,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5063593790677646,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.549529500701107,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.4278263693694895
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5736279101000449,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,0.5446432756153261,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5435753408984662,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5595507081252592,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5551864808773008,0.498979385977477
AH2018_LFQ_M_4_C,0.5252483154085251,0.4342714082163909
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5684309708665242,
LY2019_P3-,0.5182880615626267,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5301634685807439,
HS2024_8_PD_T3,0.5222398438448049,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5295613238087825,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.5757722541113794,
GF2025_P10_Adh,0.524010904300336,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5734464368329243,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5660330516456827,0.42661210776856406
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5854159394263497,
HS2024_8_I_N2,0.5456535085648201,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5438791308921083,
LY2019_P8+,0.5171673689667222,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5429829497863704,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5318681575828529,0.42999458426424664
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,0.5313920473208067,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5779507651419852,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.49361195218426585,
LY2019_P2-,0.5614016177211014,
AH2018_LFQ_IT_1_X,0.5388647439671559,
JJ2018_Ratio H/L normalized pP3___1,0.5906603249774737,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5313591227403448,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5450302042810097,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.5657787915939783,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.540376426234677,
HS2024_6_I_T1,0.551254700825199,
HS2024_5_B_T3,0.5496351232713614,
JJ2018_Ratio H/M normalized pP1___1,0.5417697021647259,
KBE2022_Log2_Ex_36_U,0.5797355528542046,
AH2018_TMTMS3_3_N,0.5891895890163265,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5290273043208373,0.49366262446213943
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5875943912196245,
KBE2022_Log2_Ex_36_T,0.5831525012351355,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.525876271429544,
KS2014_Intensity C2,0.5851835130699926,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5763897219418155,
CK2022_9 200-1,0.5703888565146781,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5690446965800251,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5446824481761285,
RBK2021_1332T Late,,
LY2019_P1-,0.48736619635560796,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5629325730407452,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5814204356523354,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5642731828472881,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5861716183115963,
RKK2015_SC-514/basal,0.5171979410615655,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5241642050886623,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5457543979280524,
HS2024_5_I_T3,0.5232777644747643,
KS2014_Intensity N1,0.5794930960192449,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.49853742312457533,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5604264883180867,
AH2018_SILAC_MR_2_C,0.542506465539315,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5245326461794043,0.41221975375893566
JJ2018_Ratio H/M normalized___1,0.5443308565913395,
RCJD2014_15min_2,0.5508582023415256,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,0.5468676700958968,
RN2012_H03,,
HS2024_5_B_N2,0.5446259238106786,
HS2024_5_I_N1,0.5376240761477811,
HS2024_6_I_N1,0.5061789376735295,
AR2021_KD 48h,,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.551476602457456,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.529001192387098,
KBE2022_Log2_Ex_29_U,0.5836597225611083,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5518356152269003,
AH2018_LFQ_IT_4_N,0.5625984798690441,
CK2022_15 200-1,0.5550468872967451,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5444500555697321,
JJ2018_Ratio M/L normalized pP3___1,0.5758997462529651,
KBE2022_Log2_Ex_34_T,0.5935936077528642,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.518041456728935,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5688562997985819,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5307332284015828,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,0.5934429651038432,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,0.39264908254620645
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5539863613811676,
HS2024_8_B_T3,0.5278464506179504,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.609709302929575,
WZ2023_Pe_010_20min,0.5336419748906698,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5619655541438092,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5610707260407107,
KS2014_Intensity C1,0.5765636832802556,
FSO2013_Ratio H/M normalized Rep3___1,0.5695219698437254,0.3939307390580275
AH2018_SILAC_M_3_C,0.5493802565657311,
RKK2015_TNF-α+IKKb/TNF-α,0.5576694963325357,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5590852945857653,0.4584540083653075
AH2018_SILAC_M_2_X,0.5530261137977629,0.4496633145785413
KTGR2014_Ratio-Rapa 15 mins,0.5033980267164146,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5686637762977318,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5267136252974024,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.5534513803501305,
JJ2018_Ratio M/L normalized pP1___1,0.5395902315180494,
AH2018_LFQ_M_3_N,0.5333338445168105,0.4409521533735413
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5558584929437245,0.4361570399199943
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.600505183207173,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5639795558389314,
GF2025_P8_Adh,0.5571926119102028,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.561912975543836,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,0.5589007478531076,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,0.48941131010291344,
EP2017_Mitotic R#1 log2 ratio,0.5864560439106712,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,0.5178314004006453,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5116508647290293,
AR2021_L41 10 μM,,
CF2017_EOC 2,0.5185669112421953,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.540713580958573,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5878094497102838,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.5605548265754599,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5632917210316947,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5656631206829296,0.4211429901375448
AR2021_L41 1 μM,,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5549273925651345,0.40802289152878846
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.5772978607634287,
ZX2022_Control Replicate 3,0.5572518827068702,
KS2014_Intensity C4,0.5941951687581147,
AS2011_Ratio H/L Inhi_2,0.5596918002912254,
KBE2022_Log2_Ex_18_T,0.6214708233552476,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5400891649523082,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5265498400094163,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5346187918098132,0.49934692128136376
WZ2023_Pu_025_10min,0.5288378055268269,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,0.5605282600929505,
RCJD2014_10min_3,0.5674389729393544,
FSO2013_Ratio M/L normalized Rep3___1,,0.5276731949561296
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5546424264626449,
CF2017_EOC 4,0.5301799271287395,
JJ2018_Ratio H/L normalized pP1___1,0.533295010654418,
WZ2023_Pe_010_30min,0.5317734061386706,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5572398236872217,0.4346747328594134
KS2014_Intensity C6,0.5858797558711374,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5584063607385044,
JJ2018_Ratio H/M normalized pP1,0.5415744224382024,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5314401763687469,0.4993128606382716
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.5668187552243945,
GF2025_P5_Adh,0.5602334777371123,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.4607385051070474
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5357362906213513,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.4995326420998114,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5280427970737208,0.49774613115959826
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5825814351770829,
AH2018_LFQ_3_C,0.5193699770169798,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5305004266721486,0.44867764838564667
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,0.4040313274060173
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5451659657327376,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5768362431862196,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5739377054544431,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5805525114405792,
KS2014_Intensity pY_N1,,0.4937053430043305
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5412039047990814,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5796922674131951,
AH2018_TMTMS2_1_X,0.5606028955886009,0.41324450260053125
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,0.5810216273820298,
ZCP2016_Ratio H/L Rep 3,0.5383398977765675,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5391525427080551,
HH2022_Reporter intensity 4,0.5406220579949704,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5745992692955832,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.4952480632815688,
HS2024_4_I_T3,0.5790285250504409,
AH2018_SILAC_1_X,0.5388536227235848,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.59382711698406,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5237994008390895,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.576950539664302,
EP2017_Untreated R#2 normalized log2 ratio,0.535652758293886,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5582846791025267,
HS2024_5_I_N2,0.5609355006073532,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5594916135523261,
AS2011_Ratio H/L Normalized RNAi_2_1,,
